Shandong Pharmaceutical Glass Co.,ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Shandong Pharmaceutical Glass Co., Ltd. is currently the world's leading manufacturer of pharmaceutical glass packaging products and butyl rubber stoppers, with over 50 years of production experience and history. It ranks among the top in various economic indicators such as production, market share, and economic benefits in the same industry in China. It is also a listed company specializing in the manufacturing of pharmaceutical glass bottles and butyl rubber stoppers in the same industry, focusing on pharmaceuticals, food The daily necessities industry serves as the target, with four subsidiaries and six subsidiaries. It is one of the few enterprises in China that can provide a complete set of "bottle+stopper+cap" drug packaging services for pharmaceutical enterprises. On January 24, 2002, with the approval of the China Securities Regulatory Commission, 32 million A-shares were issued and listed for trading on June 3, 2002. It became the first listed company in the pharmaceutical glass packaging industry in China. It is a national key high-tech enterprise, a national torch plan project enterprise, a drafting unit of national standards for pharmaceutical packaging products, an executive director unit of the China Pharmaceutical Packaging Association, one of the top ten enterprises in the national industrial key industry, one of the top 30 pharmaceutical industry enterprises in China, and a national advanced packaging enterprise, The production of pharmaceutical glass bottles and pharmaceutical butyl rubber bottle stoppers is among the top in China. The company is a joint-stock state-owned enterprise with stock code 600529. The controlling shareholder of the company is Shandong Luzhong Investment Co., Ltd. Company website: www.pharmglass.com. Unified social credit representative for business license: 91370000168611868Q. Shandong Pharmaceutical Glass maintains its leading position in the same industry in China mainly thanks to three factors: firstly, its scale advantage: its products cover glass packaging containers and auxiliary accessories for pharmaceuticals, food, and cosmetics, with 11 major series and over 500 specifications and varieties. These products include molded antibiotic bottle series, controlled bottle series, brown bottle series, neutral borosilicate glass series, infusion bottle series, daily chemical bottle series, food bottle series, butyl rubber stopper series Production and sales of pre filled syringe series, aluminum plastic cap series, and plastic bottle series (operated with a drug packaging material registration certificate), as well as the production and sales of medical devices within the scope of the license. It is suitable for the packaging needs of pharmaceutical industry powder injection, water injection, infusion, oral liquid, freeze-drying, biological agents, tablets, and other different pharmaceutical preparations, as well as food and cosmetics. There are multiple materials, bottle types, and specifications to choose from. In 34 provinces, cities, autonomous regions, and special administrative regions across the country, except for Tibet and Macau, which currently do not have Shandong Pharmaceutical Glass Company's pharmaceutical glass packaging business, all other provinces, cities, autonomous regions, and special administrative regions have Shandong Pharmaceutical Glass Company's pharmaceutical packaging business outlets, along with Shanghai Pharmaceutical Group, Guangzhou Pharmaceutical Group, Harbin Pharmaceutical Group, North China Pharmaceutical Group, Dongrui Pharmaceutical, Pfizer Pharmaceutical, Shanghai Squibb, Glaxo, Bollinger More than 3000 domestic and foreign pharmaceutical manufacturers, including Sanofi, have established long-term and stable supply relationships and are exported to multiple countries and regions such as Europe, the United States, Russia, Japan, South Korea, and Southeast Asia. The company currently has 32 workshops for production and operation, including 18 production workshops for glass products, totaling 21 kilns, 100 production lines, and a daily output of 1351 tons. It has achieved full insulation technology for kilns and automatic inspection and packaging technology for products. There are a total of 6 production workshops for rubber stoppers, aluminum plastic caps, ampoules, tube bottles, and pre filling and sealing, while there are a total of 8 auxiliary workshops for other power, gas, electromechanical, ingredient, and cardboard boxes. In 2017, the leading product, sodium calcium glass injection bottles, produced an annual output of 7 billion tubes, with a domestic market share of over 80%; The production line of sodium calcium glass molded medicine bottles (brown bottles) adopts energy-saving and fully insulated kiln technology, reducing energy consumption by more than 30%. In 2017, 2.5 billion bottles were produced, and this product is mainly used for export. The production scale of brown bottles is second to none in Asia; The annual production of medicinal butyl rubber stoppers is 4.5 billion tubes, making it the largest butyl rubber bottle stopper production line in China. The annual production of low borosilicate glass injection bottles is 1.2 billion tubes. The annual production of low borosilicate glass ampoules is 1.4 billion tubes. The annual production of sodium calcium glass daily chemical bottles is 2 billion, sodium calcium glass infusion bottles are 500 million, sodium calcium glass food bottles are 200 million, low borosilicate glass tubes are 20000 tons, medium borosilicate glass molded bottles are 200 million, blue green bottles are 200 million, medium borosilicate glass tube bottles are 20 million, medium borosilicate glass ampoules are 65 million, plastic bottles are 70.8 million, aluminum plastic caps are 500 million, pre filled syringe assemblies are 15 million, and cartridge bottles are 70 million. Secondly, the advantages of technology and equipment: The company has a postdoctoral research workstation, which pioneered and applied the 5 drop molding bottle technology in China. It has introduced advanced automated production lines and inspection packaging lines from abroad, and has been rated by the French Science and Technology Quality Supervision and Evaluation Committee as recommending products and high-quality technological products to the EU market.The company has 172 scientific and technological achievements, 146 patented technologies, and independently developed high white materials, lightweight thin-walled molded pharmaceutical glass bottles or national level new product certificates, as well as neutral borosilicate glass products, which have filled the domestic gap. The third is to create and maintain the spirit of "seeking truth, innovation, and striving" in the pharmaceutical glass industry: Shandong Pharmaceutical Glass Company obtained quality management system certification and product certification issued by the China Fangyuan Mark Certification Committee in 1998, established an environmental management system based on ISO14001 in 2003, and passed the environmental quality system certification. In 2006, it also introduced the OSAS18001 occupational health standard and passed the certification, Become an enterprise that has passed ISO19001 international quality system certification, product certification, ISO14001 environmental system certification, and GB/T28001 occupational health and safety management system certification among its peers nationwide. In September 2015, the company successfully passed the ISO15378 management system certification, providing assurance for product production process control. In September 2016, the company successfully received the ISO22000 food system certification certificate issued by the SGS certification agency, better optimizing resources and meeting the sales needs of the company's domestic and international sales markets for food series products. In December 2009, the company's quality inspection center passed the laboratory accreditation of the China National Accreditation Commission for Conformity Assessment and obtained a laboratory accreditation certificate (registration number CNASL4302), which complies with ISO/IEC17025:2005 "General Requirements for the Competence of Testing and Validation Laboratories". Not only can we effectively test and monitor the quality of various products of our company, including raw materials, semi-finished products, and finished products, but we can also act as a third party to undertake relevant testing services according to the authorized scope. |
| Headquarter | Zibo |
| Establish Date | 11/8/1993 |
| Listed Code | 600529.SH |
| Listed Date | 6/3/2002 |
| Chairman | Hu Yonggang. |
| CEO | Zhang Jun. |
| Website | www.pharmglass.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
